A regimen of prescription pills may explain the highest blood concentration of a phthalate ever observed, medical rese...
New Drug Application 9-048/S-037 Approval Date: 3/26/03 Name: 8-MOP (methoxsalen) ...
It is important to exclude prostatic abscess in patients with apparent acute prostatitis who are either seriously ill ...
Rheumatoid arthritis (RA) is a chronic, progressive disease which may lead to considerable disability. While there ar...
NEW YORK -- Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is ava...
levomethadyl acetate hydrochloride (also known as LAAM) was approved in 1993 by the U.S. Food and Drug Administration for use in the treatment of opioid dependence. Unlike methadone, which requires daily administration, LAAM is administered three times a week. Eissenberg and colleagues compared the clinical efficacy of different dosages of LAAM.